FindTrial
Sign In

Aclarubicin

DRUG5 trials

Sponsors

Washington University School of Medicine, Shandong University, Sun Yat-sen University, Shanghai Jiao Tong University School of Medicine

Conditions

Acute Myeloid LeukemiaAcute Myeloid Leukemia (AML)Cerebroretinal Vasculopathy, HereditaryElderly PatientsNewly DiagnosedRefractory Acute Myeloid Leukemia (AML)Relapse Acute Myeloid LeukemiaRelapse Leukemia

Phase 1

Aclarubicin for the Treatment of Retinal Vasculopathy With Cerebral Leukodystrophy
CompletedNCT02723448
Washington University School of MedicineCerebroretinal Vasculopathy, Hereditary, Vasculopathy, Retinal, With Cerebral Leukodystrophy
Start: 2016-12-05End: 2020-07-23Updated: 2020-11-19
Aclarubicin Plus With Azacitidine and Venetoclax in the Treatment of Acute Myeloid Leukemia
Not yet recruitingNCT07486726
Shanghai Jiao Tong University School of MedicineAcute Myeloid Leukemia (AML), Refractory Acute Myeloid Leukemia (AML), Relapse Acute Myeloid Leukemia
Start: 2026-03-15End: 2028-10-01Target: 112Updated: 2026-03-20

Phase 2

Clinical Trial of Ara-C, Aclarubicin Combined With PEG-G-CSF for Initial Treatment of AML Patients
NCT03045627
Shandong UniversityAcute Myeloid Leukemia
Start: 2017-01-31End: 2020-07-31Target: 120Updated: 2017-02-07
Cladribine in Combination With CAG in Patients With Refractory/Relapsed Acute Myeloid Leukemia
NCT03181815
Sun Yat-sen UniversityAcute Myeloid Leukemia, Relapse Leukemia
Start: 2016-01-01End: 2019-12-31Target: 48Updated: 2019-08-20
Efficacy and Safety of Cladribine in Combination With CAG in Newly Diagnosed Unfit Patients With AML
NCT04254640
Sun Yat-sen UniversityAcute Myeloid Leukemia, Elderly Patients, Newly Diagnosed
Start: 2021-03-01End: 2023-12-31Target: 34Updated: 2020-12-17